gritt.io›Find investors›Pharmaceutical in United States

Top 2026 Pharmaceutical Early Stage Investors in United States

Discover the top 868 pharmaceutical early stage investors in United States based on their portfolio. Get their email and LinkedIn info.

868
Investors
695
With email
80%
Email rate
Nov 2026
Last updated

Investor search results

873 investors found
🌍 United States📊 early stage🏷 Pharmaceutical
Caroline Farah Lembck, MBA, PhD (abd)
Caroline Farah Lembck, MBA, PhD (abd)
American Businesswoman, Investor & Entrepreneur Founder of LemVega Capital®, Puerto Rico’s leading investment firm going global | Featured NasDaq, Forbes | BA at 19 years old | MBA at 20 | PhD started at 20 | CEO at 21
Late stage19 in Pharmaceutical76 investments 📍 United States
19
in Pharmaceutical
LL
Lennart Lee
Life Sciences Investor & Entrepreneur
Early stage15 in Pharmaceutical35 investments 📍 United States
15
in Pharmaceutical
Alaa Halawa
Alaa Halawa
Investing in and building transformative companies at the intersection of technology and healthcare
Early stage9 in Pharmaceutical24 investments 📍 United States
9
in Pharmaceutical
Paulina Hill
Paulina Hill
Partner and Head of Investments, Sanofi Ventures
Early stage8 in Pharmaceutical15 investments 📍 United States
8
in Pharmaceutical
ST
Sean Trigony
Investor
Early stage8 in Pharmaceutical57 investments 📍 United States
8
in Pharmaceutical
LI
Lucio Iannone
Investor at Leaps by Bayer
Early stage8 in Pharmaceutical21 investments 📍 United States
8
in Pharmaceutical
Tim Walbert
Tim Walbert
Managing Partner, HRZN Partners LLC; Sr. Advisor, Amgen; Sr. Advisor, Patient Square Capital
Mid stage7 in Pharmaceutical18 investments 📍 United States
7
in Pharmaceutical
Joseph Oberholtzer
Joseph Oberholtzer
Director of Strategic Finance at Vera Therapeutics
Mid stage7 in Pharmaceutical10 investments 📍 United States
7
in Pharmaceutical
Patrick Heron
Patrick Heron
Managing Partner at Frazier Life Sciences
Early stage7 in Pharmaceutical31 investments 📍 United States
7
in Pharmaceutical
Ayman A.
Ayman A.
Investing in venture and growth-stage companies transforming industries
Early stage7 in Pharmaceutical36 investments 📍 United States
7
in Pharmaceutical

Frequently asked questions about Pharmaceutical investors in United States

How many Pharmaceutical early-stage investors are there in United States?
Gritt tracks 868 Pharmaceutical early-stage investors in United States, of which 695 (80%) have a direct email address available.
How can I contact Pharmaceutical investors in United States?
Gritt provides direct email addresses for 80% of investors in this list. On a paid plan you can unlock them and export the list, or use Gritt AI outreach to draft personalised emails that you approve, or let Gritt approve, and send from your Gmail.
Are these investors actively investing in United States startups?
Gritt lists them most active first, by the number of deals they have made in Pharmaceutical, and each profile shows those deals and their dates. To see only investors who have invested recently, use the Last active filter.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Pharmaceutical investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.

Contact all 868 Pharmaceutical early-stage investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required